Skip to main content

CMS Report Reveals Gender Disparities in Care Quality

News  |  By Revenue Cycle Advisor  
   July 06, 2017

Gender disparities shed light on gaps in patient care. 

This article was originally published on Revenue Cycle Advisor, May 30, 2017.

Two of the most significant healthcare gender disparities are related to follow-up care and alcohol/drug treatment, according to Gender Disparities In Health Care in Medicare Advantage, a report released by the CMS Office of Minority Health in April based on 2015 data.

Examining 24 clinical care measures, the report revealed that women receive worse care than men for three measures, similar care for 16, and better care than men for five measures. For the purpose of this report, disparities in care are considered statistically significant if the difference between men and women receiving the care is three or more points after rounding. 

The most significant disparity where men received better clinical care was avoiding potentially harmful drug-disease interactions in elderly patients with a history of falls. According to the report, 61% of elderly men met the standard of care, compared to approximately 50% of elderly women. Meanwhile, the top disparity where women received better clinical care occurred in follow-up after a hospital stay for mental illness (within 30 days of discharge). About 57% of women received follow-up care compared to about 50% of men.

Women received significantly better care than men in the following areas:

  • Follow-up after a hospital stay for mental illness (within 30 days of discharge) by 7.7%
  • Follow-up after a hospital stay for mental illness (within seven days of discharge) by 4.8%
  • Diabetes care—eye exam by 3.2%
  • Management of COPD exacerbation—bronchodilator by 3.6%
  • Rheumatoid arthritis management by 3.1%

Men received significantly better care than women in the following areas:

  • Avoiding potentially harmful drug-disease interactions in elderly patients with a history of falls by 11.3%
  • Avoiding potentially harmful drug-disease interactions in elderly patients with dementia by 8.3%
  • Initiation of alcohol or other drug treatment by 6.3%

Revenue Cycle Advisor combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule and regulatory updates thoroughly. Learn more.


Get the latest on healthcare leadership in your inbox.